Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.

P97523

- MET_RAT

UniProt

P97523 - MET_RAT

(max 400 entries)x

Your basket is currently empty.

Select item(s) and click on "Add to basket" to create your own collection here
(400 entries max)

Protein

Hepatocyte growth factor receptor

Gene

Met

Organism
Rattus norvegicus (Rat)
Status
Reviewed - Annotation score: 5 out of 5- Experimental evidence at protein leveli

Functioni

Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to hepatocyte growth factor/HGF ligand. Regulates many physiological processes including proliferation, scattering, morphogenesis and survival. Ligand binding at the cell surface induces autophosphorylation of MET on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with the PI3-kinase subunit PIK3R1, PLCG1, SRC, GRB2, STAT3 or the adapter GAB1. Recruitment of these downstream effectors by MET leads to the activation of several signaling cascades including the RAS-ERK, PI3 kinase-AKT, or PLCgamma-PKC. The RAS-ERK activation is associated with the morphogenetic effects while PI3K/AKT coordinates prosurvival effects. During embryonic development, MET signaling plays a role in gastrulation, development and migration of muscles and neuronal precursors, angiogenesis and kidney formation. In adults, participates in wound healing as well as organ regeneration and tissue remodeling. Promotes also differentiation and proliferation of hematopoietic cells (By similarity).By similarity

Catalytic activityi

ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.PROSITE-ProRule annotation

Enzyme regulationi

In its inactive state, the C-terminal tail interacts with the catalytic domain and inhibits the kinase activity. Upon ligand binding, the C-terminal tail is displaced and becomes phosphorylated, thus increasing the kinase activity (By similarity).By similarity

Sites

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Sitei308 – 3092CleavageSequence Analysis
Binding sitei1111 – 11111ATPPROSITE-ProRule annotation
Active sitei1205 – 12051Proton acceptorPROSITE-ProRule annotation

Regions

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Nucleotide bindingi1085 – 10939ATPPROSITE-ProRule annotation

GO - Molecular functioni

  1. ATP binding Source: UniProtKB-KW
  2. beta-catenin binding Source: RGD
  3. hepatocyte growth factor-activated receptor activity Source: RGD
  4. phosphatidylinositol 3-kinase binding Source: RGD
  5. phospholipase binding Source: RGD
  6. protein complex binding Source: RGD
  7. protein heterodimerization activity Source: RGD
  8. protein tyrosine kinase activity Source: RGD

GO - Biological processi

  1. brain development Source: RGD
  2. cell aging Source: RGD
  3. cellular response to arsenic-containing substance Source: RGD
  4. cellular response to glucose stimulus Source: RGD
  5. cellular response to growth factor stimulus Source: RGD
  6. cellular response to inorganic substance Source: RGD
  7. cellular response to interleukin-6 Source: RGD
  8. cellular response to peptide hormone stimulus Source: RGD
  9. central nervous system neuron differentiation Source: RGD
  10. hepatocyte growth factor receptor signaling pathway Source: GOC
  11. lactation Source: RGD
  12. liver development Source: RGD
  13. male gonad development Source: RGD
  14. negative regulation of peptidyl-threonine phosphorylation Source: RGD
  15. negative regulation of transcription from RNA polymerase II promoter Source: RGD
  16. neuron migration Source: RGD
  17. oligodendrocyte development Source: RGD
  18. pancreas development Source: RGD
  19. peptidyl-tyrosine phosphorylation Source: GOC
  20. positive chemotaxis Source: UniProtKB
  21. positive regulation of dendrite morphogenesis Source: RGD
  22. positive regulation of DNA replication Source: RGD
  23. positive regulation of endothelial cell chemotaxis Source: UniProtKB
  24. positive regulation of gene expression Source: RGD
  25. positive regulation of mitosis Source: RGD
  26. positive regulation of neuron projection development Source: RGD
  27. positive regulation of peptidyl-serine phosphorylation Source: RGD
  28. positive regulation of peptidyl-threonine phosphorylation Source: RGD
  29. positive regulation of transcription from RNA polymerase II promoter Source: RGD
  30. protein autophosphorylation Source: RGD
  31. response to acidic pH Source: RGD
  32. response to drug Source: RGD
  33. response to organic cyclic compound Source: RGD
  34. response to peptide hormone Source: RGD
  35. response to wounding Source: RGD
  36. semaphorin-plexin signaling pathway Source: UniProtKB
  37. sperm motility Source: RGD
Complete GO annotation...

Keywords - Molecular functioni

Kinase, Receptor, Transferase, Tyrosine-protein kinase

Keywords - Ligandi

ATP-binding, Nucleotide-binding

Enzyme and pathway databases

BRENDAi2.7.10.1. 5301.

Names & Taxonomyi

Protein namesi
Recommended name:
Hepatocyte growth factor receptor (EC:2.7.10.1)
Short name:
HGF receptor
Alternative name(s):
HGF/SF receptor
Proto-oncogene c-Met
Scatter factor receptor
Short name:
SF receptor
Tyrosine-protein kinase Met
Gene namesi
Name:Met
OrganismiRattus norvegicus (Rat)
Taxonomic identifieri10116 [NCBI]
Taxonomic lineageiEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresGliresRodentiaSciurognathiMuroideaMuridaeMurinaeRattus
ProteomesiUP000002494: Unplaced

Organism-specific databases

RGDi3082. Met.

Subcellular locationi

GO - Cellular componenti

  1. cytoplasm Source: RGD
  2. dendrite Source: RGD
  3. excitatory synapse Source: RGD
  4. extracellular space Source: RGD
  5. integral component of membrane Source: RGD
  6. neuronal cell body Source: RGD
  7. neuron projection Source: RGD
  8. plasma membrane Source: RGD
  9. postsynaptic density Source: RGD
  10. postsynaptic membrane Source: RGD
  11. sperm flagellum Source: RGD
Complete GO annotation...

Keywords - Cellular componenti

Membrane

Pathology & Biotechi

Keywords - Diseasei

Proto-oncogene

PTM / Processingi

Molecule processing

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Signal peptidei1 – 2424Sequence AnalysisAdd
BLAST
Chaini25 – 13821358Hepatocyte growth factor receptorPRO_0000024442Add
BLAST

Amino acid modifications

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Glycosylationi45 – 451N-linked (GlcNAc...)Sequence Analysis
Disulfide bondi95 ↔ 101PROSITE-ProRule annotation
Disulfide bondi98 ↔ 160PROSITE-ProRule annotation
Glycosylationi106 – 1061N-linked (GlcNAc...)Sequence Analysis
Disulfide bondi133 ↔ 141PROSITE-ProRule annotation
Disulfide bondi173 ↔ 176PROSITE-ProRule annotation
Glycosylationi203 – 2031N-linked (GlcNAc...)Sequence Analysis
Disulfide bondi299 ↔ 364PROSITE-ProRule annotation
Glycosylationi359 – 3591N-linked (GlcNAc...)Sequence Analysis
Disulfide bondi386 ↔ 398PROSITE-ProRule annotation
Glycosylationi400 – 4001N-linked (GlcNAc...)Sequence Analysis
Glycosylationi406 – 4061N-linked (GlcNAc...)Sequence Analysis
Disulfide bondi521 ↔ 539PROSITE-ProRule annotation
Disulfide bondi527 ↔ 562PROSITE-ProRule annotation
Disulfide bondi530 ↔ 546PROSITE-ProRule annotation
Disulfide bondi542 ↔ 552PROSITE-ProRule annotation
Glycosylationi608 – 6081N-linked (GlcNAc...)Sequence Analysis
Glycosylationi636 – 6361N-linked (GlcNAc...)Sequence Analysis
Glycosylationi786 – 7861N-linked (GlcNAc...)Sequence Analysis
Glycosylationi880 – 8801N-linked (GlcNAc...)Sequence Analysis
Modified residuei978 – 9781PhosphothreonineBy similarity
Modified residuei991 – 9911PhosphoserineBy similarity
Modified residuei998 – 9981PhosphoserineBy similarity
Modified residuei1001 – 10011PhosphoserineBy similarity
Modified residuei1004 – 10041PhosphotyrosineBy similarity
Modified residuei1231 – 12311PhosphotyrosineBy similarity
Modified residuei1235 – 12351Phosphotyrosine; by autocatalysisBy similarity
Modified residuei1236 – 12361Phosphotyrosine; by autocatalysisBy similarity
Modified residuei1290 – 12901PhosphothreonineBy similarity
Modified residuei1350 – 13501Phosphotyrosine; by autocatalysisBy similarity
Modified residuei1357 – 13571Phosphotyrosine; by autocatalysisBy similarity
Modified residuei1366 – 13661PhosphotyrosineBy similarity

Post-translational modificationi

Autophosphorylated in response to ligand binding on Tyr-1235 and Tyr-1236 in the kinase domain leading to further phosphorylation of Tyr-1350 and Tyr-1357 in the C-terminal multifunctional docking site. Dephosphorylated by PTPRJ at Tyr-1350 and Tyr-1366. Dephosphorylated by PTPN1 and PTPN2 (By similarity).By similarity
Ubiquitinated. Ubiquitination by CBL regulates the receptor stability and activity through proteasomal degradation (By similarity).By similarity

Keywords - PTMi

Disulfide bond, Glycoprotein, Phosphoprotein, Ubl conjugation

Proteomic databases

PaxDbiP97523.
PRIDEiP97523.

PTM databases

PhosphoSiteiP97523.

Expressioni

Tissue specificityi

Expressed at highest levels in lung, liver and kidney, also expressed in stomach, intestine, spleen, testis and brain. Not expressed in heart or muscle.

Developmental stagei

Expression is down-regulated during pregnancy and is virtually undetectable during lactation. Expression progressively increases post-lactation.

Inductioni

By interleukin-6 and acute acid-induced gastric injury. Inhibited by prolactin.

Gene expression databases

GenevestigatoriP97523.

Interactioni

Subunit structurei

Heterodimer made of an alpha chain (50 kDa) and a beta chain (145 kDa) which are disulfide linked. Binds PLXNB1. Interacts when phosphorylated with downstream effectors including STAT3, PIK3R1, SRC, PCLG1, GRB2 and GAB1. Interacts with SPSB1, SPSB2 and SPSB4 (By similarity). Interacts with INPP5D/SHIP1. When phosphorylated at Tyr-1357, interacts with INPPL1/SHIP2. Interacts with RANBP9 and RANBP10, as well as SPSB1, SPSB2, SPSB3 and SPSB4. SPSB1 binding occurs in the presence and in the absence of HGF, however HGF treatment has a positive effect on this interaction. Interacts with MUC20; prevents interaction with GRB2 and suppresses hepatocyte growth factor-induced cell proliferation. Interacts with GRB10 (By similarity). Interacts with PTPN1 and PTPN2 (By similarity).By similarity

Structurei

3D structure databases

ProteinModelPortaliP97523.
SMRiP97523. Positions 40-742, 1047-1347.
ModBaseiSearch...
MobiDBiSearch...

Topological domain

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Topological domaini25 – 935911ExtracellularSequence AnalysisAdd
BLAST
Topological domaini957 – 1379423CytoplasmicSequence AnalysisAdd
BLAST

Transmembrane

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Transmembranei936 – 95621HelicalSequence AnalysisAdd
BLAST

Family & Domainsi

Domains and Repeats

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Domaini27 – 516490SemaPROSITE-ProRule annotationAdd
BLAST
Domaini564 – 65693IPT/TIG 1Add
BLAST
Domaini658 – 74083IPT/TIG 2Add
BLAST
Domaini743 – 83795IPT/TIG 3Add
BLAST
Domaini1079 – 1346268Protein kinasePROSITE-ProRule annotationAdd
BLAST

Region

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Regioni1213 – 1382170Interaction with RANBP9By similarityAdd
BLAST
Regioni1321 – 136040Interaction with MUC20By similarityAdd
BLAST

Domaini

The kinase domain is involved in SPSB1 binding.By similarity
The beta-propeller Sema domain mediates binding to HGF.By similarity

Sequence similaritiesi

Belongs to the protein kinase superfamily. Tyr protein kinase family.PROSITE-ProRule annotation
Contains 3 IPT/TIG domains.Curated
Contains 1 protein kinase domain.PROSITE-ProRule annotation
Contains 1 Sema domain.PROSITE-ProRule annotation

Keywords - Domaini

Repeat, Signal, Transmembrane, Transmembrane helix

Phylogenomic databases

eggNOGiCOG0515.
HOGENOMiHOG000220900.
HOVERGENiHBG006348.
InParanoidiP97523.
KOiK05099.
PhylomeDBiP97523.

Family and domain databases

Gene3Di2.130.10.10. 1 hit.
2.60.40.10. 3 hits.
InterProiIPR013783. Ig-like_fold.
IPR014756. Ig_E-set.
IPR002909. IPT.
IPR011009. Kinase-like_dom.
IPR016201. Plexin-like_fold.
IPR002165. Plexin_repeat.
IPR000719. Prot_kinase_dom.
IPR017441. Protein_kinase_ATP_BS.
IPR001627. Semap_dom.
IPR001245. Ser-Thr/Tyr_kinase_cat_dom.
IPR008266. Tyr_kinase_AS.
IPR020635. Tyr_kinase_cat_dom.
IPR016244. Tyr_kinase_HGF/MSP_rcpt.
IPR015943. WD40/YVTN_repeat-like_dom.
[Graphical view]
PfamiPF07714. Pkinase_Tyr. 1 hit.
PF01437. PSI. 1 hit.
PF01403. Sema. 1 hit.
PF01833. TIG. 3 hits.
[Graphical view]
PIRSFiPIRSF000617. TyrPK_HGF-R. 1 hit.
PRINTSiPR00109. TYRKINASE.
SMARTiSM00429. IPT. 4 hits.
SM00423. PSI. 1 hit.
SM00630. Sema. 1 hit.
SM00219. TyrKc. 1 hit.
[Graphical view]
SUPFAMiSSF101912. SSF101912. 1 hit.
SSF103575. SSF103575. 1 hit.
SSF56112. SSF56112. 1 hit.
SSF81296. SSF81296. 3 hits.
PROSITEiPS00107. PROTEIN_KINASE_ATP. 1 hit.
PS50011. PROTEIN_KINASE_DOM. 1 hit.
PS00109. PROTEIN_KINASE_TYR. 1 hit.
PS51004. SEMA. 1 hit.
[Graphical view]

Sequencei

Sequence statusi: Complete.

Sequence processingi: The displayed sequence is further processed into a mature form.

P97523 [UniParc]FASTAAdd to Basket

« Hide

        10         20         30         40         50
MKAPTALAPG ILLLLLTLAQ RSHGECKEAL VKSEMNVNMK YQLPNFTAET
60 70 80 90 100
PIHNVVLPGH HIYLGATNYI YVLNDKDLQK VSEFKTGPVV EHPDCFPCQD
110 120 130 140 150
CSSKANVSGG VWKDNVNMAL LVDTYYDDQL ISCGSVNRGT CQRHVLPPDN
160 170 180 190 200
AADIQSEVHC MFSPLAEEES GQCPDCVVSA LGAKVLLSEK DRFINFFVGN
210 220 230 240 250
TINSSYPPDY SLHSISVRRL KETQDGFKFL TDQSYIDVLP EFRDSYPIKY
260 270 280 290 300
IHAFESNHFI YFLTVQKETL DAQTFHTRII RFCSVDSGLH SYMEMPLECI
310 320 330 340 350
LTEKRRKRST REEVFNILQA AYVSKPGANL AKQIGASPYD DILYGVFAQS
360 370 380 390 400
KPDSAEPMNR SAVCAFPIKY VNDFFNKIVN KNNVRCLQHF YGPNHEHCFN
410 420 430 440 450
RTLLRNSSGC EVRSDEYRTE FTTALQRVDL FMGRLNHVLL TSISTFIKGD
460 470 480 490 500
LTIANLGTSE GRFMQVVLSR TAHFTPHVNF LLDSYPVSPE VIVEHPSNQN
510 520 530 540 550
GYTLVVTGKK ITKIPLNGLG CGHFQSCSQC LSPPYFIQCG WCHNRCVHSN
560 570 580 590 600
ECPSGTWTQE ICLPAVYKVF PTSAPLEGGT MLTICGWDFG FKKNNKFDLR
610 620 630 640 650
KTKVLLGNES CTLTLSESTT NTLKCTVGPA MSEHFNVSVI VSNSRETTQY
660 670 680 690 700
SAFSYVDPVI TSISPRYGPH AGGTLLTLTG KYLNSGNSRH ISIGGKTCTL
710 720 730 740 750
KSVSDSILEC YTPGHTVSAE FPVKLKIDLA DRVTSSFSYR EDPVVSEIHP
760 770 780 790 800
TKSFISGGST ITGIGKNLNS VSTPKLVIEV HDVGVNYTVA CQHRSSSEII
810 820 830 840 850
CCTTPSLRQL DLQLPLKTKA FFLLDGILSK HFDLTYVHDP MFKPFEKPVM
860 870 880 890 900
ISMGNENVVE IKGDDIDPEA VKGEVLKVGN KSCENLHWHS EALLCTVPSD
910 920 930 940 950
LLKLNGGELN IEWKQAVSST VLGKVIVQPD QNFAGLIIGA VSISVVVLLV
960 970 980 990 1000
SGLFLWLRKR KHKDLGSELV RYDARVHTPH LDRLVSARSV SPTTEMVSNE
1010 1020 1030 1040 1050
SVDYRATFPE DQFPNSSQNG ACRQVQYLLT DLSPILTSGD SDISSPLLQN
1060 1070 1080 1090 1100
TVHIDLSALN PELVQAVPHV VIGPSSLIVH FNEVIGRGHF GCVYHGTLLD
1110 1120 1130 1140 1150
SDGKKIHCAV KSLNRITDIE EVSQFLTEGI IMKDFSHPNV LSLLGICLRS
1160 1170 1180 1190 1200
EGSPLVVLPY MKHGDLRNFI RNETHNPTVK DLIGFGLQVA KGMKYLVSKK
1210 1220 1230 1240 1250
FVHRDLAARN CMLDEKFTVK VADFGLARDM YDKEYYSVHN KTGAKLPVKW
1260 1270 1280 1290 1300
MALESLQTQK FTTKSDVWSF GVLLWELMTR GAPPYPDVNT FDITIYLLQG
1310 1320 1330 1340 1350
RRLLQPEYCP DALYEVMLKC WHPKAEMRPS VSELVSRISS IFSTFIGEHY
1360 1370 1380
VHVNATYVNV KCVAPYPSLL PSQDNIDGEA NT
Length:1,382
Mass (Da):153,941
Last modified:May 1, 1997 - v1
Checksum:i66B8F2C88FE34427
GO

Experimental Info

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Sequence conflicti53 – 531H → Q in AAB19189. (PubMed:8853431)Curated
Sequence conflicti58 – 581P → H in AAB19189. (PubMed:8853431)Curated
Sequence conflicti240 – 2401P → G in AAB19189. (PubMed:8853431)Curated
Sequence conflicti427 – 4271R → A in AAB19189. (PubMed:8853431)Curated
Sequence conflicti485 – 4851Y → H in AAB19189. (PubMed:8853431)Curated
Sequence conflicti490 – 4956EVIVEH → GAAGIR(PubMed:8166728)Curated
Sequence conflicti533 – 5331P → A in AAB19189. (PubMed:8853431)Curated
Sequence conflicti740 – 7401R → G in AAB19189. (PubMed:8853431)Curated
Sequence conflicti744 – 7441V → F in AAB19189. (PubMed:8853431)Curated
Sequence conflicti808 – 8081R → Q in AAB19189. (PubMed:8853431)Curated
Sequence conflicti890 – 8934SEAL → TASV in CAA86508. (PubMed:7628535)Curated
Sequence conflicti907 – 9071Missing in CAA86508. (PubMed:7628535)Curated
Sequence conflicti924 – 9241K → E in CAA86508. (PubMed:7628535)Curated
Sequence conflicti934 – 9341A → R in CAA86508. (PubMed:7628535)Curated
Sequence conflicti1028 – 10281L → P in AAB19189. (PubMed:8853431)Curated
Sequence conflicti1068 – 10681P → Q in AAB19189. (PubMed:8853431)Curated
Sequence conflicti1197 – 11971V → A(PubMed:8853431)Curated
Sequence conflicti1197 – 11971V → A1 PublicationCurated
Sequence conflicti1331 – 13311V → F in AAB19189. (PubMed:8853431)Curated

Sequence databases

Select the link destinations:
EMBL
GenBank
DDBJ
Links Updated
X96786 mRNA. Translation: CAA65582.1.
U65007 mRNA. Translation: AAB19189.1.
S69881 mRNA. Translation: AAB30575.1.
Z46374 mRNA. Translation: CAA86508.1.
AB012281 Genomic DNA. Translation: BAA28171.1.
PIRiPC2131.
RefSeqiNP_113705.1. NM_031517.2.
UniGeneiRn.10617.

Genome annotation databases

GeneIDi24553.
KEGGirno:24553.
UCSCiRGD:3082. rat.

Cross-referencesi

Sequence databases

Select the link destinations:
EMBL
GenBank
DDBJ
Links Updated
X96786 mRNA. Translation: CAA65582.1 .
U65007 mRNA. Translation: AAB19189.1 .
S69881 mRNA. Translation: AAB30575.1 .
Z46374 mRNA. Translation: CAA86508.1 .
AB012281 Genomic DNA. Translation: BAA28171.1 .
PIRi PC2131.
RefSeqi NP_113705.1. NM_031517.2.
UniGenei Rn.10617.

3D structure databases

ProteinModelPortali P97523.
SMRi P97523. Positions 40-742, 1047-1347.
ModBasei Search...
MobiDBi Search...

PTM databases

PhosphoSitei P97523.

Proteomic databases

PaxDbi P97523.
PRIDEi P97523.

Protocols and materials databases

Structural Biology Knowledgebase Search...

Genome annotation databases

GeneIDi 24553.
KEGGi rno:24553.
UCSCi RGD:3082. rat.

Organism-specific databases

CTDi 4233.
RGDi 3082. Met.

Phylogenomic databases

eggNOGi COG0515.
HOGENOMi HOG000220900.
HOVERGENi HBG006348.
InParanoidi P97523.
KOi K05099.
PhylomeDBi P97523.

Enzyme and pathway databases

BRENDAi 2.7.10.1. 5301.

Miscellaneous databases

NextBioi 603662.
PROi P97523.

Gene expression databases

Genevestigatori P97523.

Family and domain databases

Gene3Di 2.130.10.10. 1 hit.
2.60.40.10. 3 hits.
InterProi IPR013783. Ig-like_fold.
IPR014756. Ig_E-set.
IPR002909. IPT.
IPR011009. Kinase-like_dom.
IPR016201. Plexin-like_fold.
IPR002165. Plexin_repeat.
IPR000719. Prot_kinase_dom.
IPR017441. Protein_kinase_ATP_BS.
IPR001627. Semap_dom.
IPR001245. Ser-Thr/Tyr_kinase_cat_dom.
IPR008266. Tyr_kinase_AS.
IPR020635. Tyr_kinase_cat_dom.
IPR016244. Tyr_kinase_HGF/MSP_rcpt.
IPR015943. WD40/YVTN_repeat-like_dom.
[Graphical view ]
Pfami PF07714. Pkinase_Tyr. 1 hit.
PF01437. PSI. 1 hit.
PF01403. Sema. 1 hit.
PF01833. TIG. 3 hits.
[Graphical view ]
PIRSFi PIRSF000617. TyrPK_HGF-R. 1 hit.
PRINTSi PR00109. TYRKINASE.
SMARTi SM00429. IPT. 4 hits.
SM00423. PSI. 1 hit.
SM00630. Sema. 1 hit.
SM00219. TyrKc. 1 hit.
[Graphical view ]
SUPFAMi SSF101912. SSF101912. 1 hit.
SSF103575. SSF103575. 1 hit.
SSF56112. SSF56112. 1 hit.
SSF81296. SSF81296. 3 hits.
PROSITEi PS00107. PROTEIN_KINASE_ATP. 1 hit.
PS50011. PROTEIN_KINASE_DOM. 1 hit.
PS00109. PROTEIN_KINASE_TYR. 1 hit.
PS51004. SEMA. 1 hit.
[Graphical view ]
ProtoNeti Search...

Publicationsi

  1. "Chromosomal localization of rat hepatocyte growth factor (Hgf) and HGF receptor (Met) and characterization of HGF receptor cDNA."
    Wallenius V.R., Rawet H., Skrtic S., Helou K., Qiu Y., Levan G., Ekberg S., Carlsson B., Isaksson O.G.P., Nakamura T., Jansson J.-O.
    Mamm. Genome 8:661-667(1997) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA].
    Strain: Sprague-Dawley.
    Tissue: Liver.
  2. "Primary structure of rat HGF receptor and induced expression in glomerular mesangial cells."
    Liu Y., Tolbert E.M., Sun A.M., Dworkin L.D.
    Am. J. Physiol. 271:F679-F688(1996) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION.
    Strain: Sprague-Dawley.
    Tissue: Kidney.
  3. Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 364-495.
    Strain: Sprague-Dawley.
    Tissue: Gastric mucosa.
  4. "Modulation of hepatocyte growth factor and c-met in the rat mammary gland during pregnancy, lactation, and involution."
    Pepper M.S., Soriano J.V., Menoud P.-A., Sappino A.-P., Orci L., Montesano R.
    Exp. Cell Res. 219:204-210(1995) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 851-1002.
    Tissue: Intestine.
  5. Kikuchi Y.
    Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1129-1267.

Entry informationi

Entry nameiMET_RAT
AccessioniPrimary (citable) accession number: P97523
Secondary accession number(s): P97579, Q63119, Q63964
Entry historyi
Integrated into UniProtKB/Swiss-Prot: April 27, 2001
Last sequence update: May 1, 1997
Last modified: October 29, 2014
This is version 144 of the entry and version 1 of the sequence. [Complete history]
Entry statusiReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program

Miscellaneousi

Keywords - Technical termi

Complete proteome, Reference proteome

Documents

  1. SIMILARITY comments
    Index of protein domains and families

External Data

Dasty 3